BRAF and colorectal carcinoma: According to a systematic review of patients with BRAF-mutated CRC, MSS was associated with worse prognosis than MSI, but the clinical stratification by MSI testing and heterogeneity of genetic mutations have not been established for patients with BRAF-mutated synchronous CRC [40].